Related Experiment Videos
[Hyperlipidemia and coronary heart disease]
W Schützenberger1, W Harringer, F Leisch
1I. Medizinischen Abteilung, Allgemeinen Krankenhauses der Stadt Linz.
Wiener Medizinische Wochenschrift. Supplement
|January 1, 1989
Summary
High cholesterol, particularly LDL, is linked to coronary heart disease. Lowering cholesterol through diet or medication effectively reduces heart events and mortality risk.
Area of Science:
- Cardiology
- Lipid Metabolism
- Preventive Medicine
Context:
- Established link between elevated total and LDL-cholesterol and coronary heart disease (CHD) incidence.
- Inverse relationship observed between HDL-cholesterol and cardiac mortality/myocardial infarction.
- Elevated triglycerides may be an additional risk factor for cardiovascular events.
Purpose:
- To review the established relationships between lipid profiles and coronary heart disease.
- To highlight the efficacy of lipid-lowering interventions in reducing cardiovascular morbidity and mortality.
- To emphasize the clinical utility of risk identification and targeted therapy for hyperlipidemia.
Summary:
- High total serum cholesterol (>200 mg/dl) and LDL-cholesterol (>155 mg/dl) are well-established risk factors for coronary heart disease.
- Conversely, lower HDL-cholesterol levels correlate with increased cardiac death and non-fatal myocardial infarction.
- Studies confirm that interventions like fat-modified diets and drug treatments for hyperlipidemia significantly reduce CHD morbidity and mortality.
Impact:
- Effective management of hyperlipidemia, guided by lipid profiles, can significantly lower the risk of coronary events.
- Clinicians can identify high-risk individuals and initiate personalized therapies based on European Atherosclerosis Society guidelines.
- Reduction in coronary events directly correlates with the degree of reduction in total cholesterol and LDL-cholesterol.